Printer Friendly

Health care firms bring talent aboard.

In keeping with the health care theme of this edition of Directors & Boards, we present a selection of directors who joined the boards of health care-related companies during the fall of 1991.

Author and international health commentator Miriam Stoppard, M.D., was elected to the board of Syntex Corp. Dr. Stoppard, who has authored more than 25 books, specializes in child care and baby care issues. She lives in London, where she is currently anchoring a daily news program on BBC1. She began her medical career as a house surgeon in 1961 at the Royal Victoria Infirmary in Newcastle, England. She was employed by Syntex from 1968 to 1980, when she left to pursue her broadcast and writing interests. Syntex, headquartered in Palo Alto, Calif., is a multinational health care company operating in the prescription medicine, animal pharmaceutical, and medical imaging systems markets.

Warner-Lambert Co. elected William H. Gray III to its board. Gray is president of the United Negro College Fund. He joined the UNCF last year following a career in Congress, where he served as House Majority Whip and was the House's third-highest ranking Democrat prior to his resignation. Other companies that latched onto the newly "privatized" Gray for a board position are Grumman Corp., Prudential Insurance Co. of America, and Westinghouse Electric Corp. Based in Morris Plains, N.J., Warner-Lambert develops, manufactures, and markets health care and consumer products.

ProCyte Corp. added Jules Blake and William M. Sullivan to its board. Dr. Blake is the former vice president of corporate scientific affairs for Colgate-Palmolive Co., where he also served as vice president of research and development. At Colgate, he established the technology acquisition program responsible for evaluating and forming strategic alliances, research contracts, equity positions, and joint ventures. Sullivan is the former chairman, president, and CEO of Burroughs Wellcome Co., where, during his tenure, the company achieved the highest overall growth rate among the top 20 U.S. pharmaceutical companies. He retired from Burroughs Wellcome in 1986 and has served as chairman of Immune Response Corp. since its founding in 1987. ProCyte, located in Kirkland, Wash., is a developer of peptide-based compounds for wound healing and tissue repair applications. It has three drugs in clinical study.

Synergen Inc. elected Barry MacTaggart to its board. MacTaggart is the retired chairman and president of Pfizer International. He began his career as a chartered accountant at Peat Marwick in Australia. He joined Pfizer International in 1959 in its Hong Kong office and rose to the presidency in 1981. He was also a member of the board of Pfizer Inc. Synergen, based in Boulder, Colo., is a biopharmaceutical company developing products to treat inflammatory diseases and other disorders using recombinant DNA technology and the latest advances in molecular and cellular biology and manufacturing technology.

Ribi ImmunoChem Research Inc. has elected Mark S. Germain as a director. Germain has been managing director of D. Blech & Co. since April 1990. Previously, he was president and CEO of The Vista Organization Ltd. and, prior to that, a partner in the law firm of Finley, Kumble, Wagner, Heine, Underberg, Manley, Meyerson & Casey. Ribi ImmunoChem, of Hamilton, Mont., is a biopharmaceutical company founded in 1981. It is developing immunostimulants for use in preventing and treating human and animal diseases.

Medicine Shoppe International Inc. elected Dr. Murray Weidenbaum to its board. Weidenbaum currently holds the Mallinckrodt Distinguished University Professorship at Washington University in St. Louis, where he also serves as director of the university's Center for the Study of American Business. He also served in the early 1980s as President Reagan's first chairman of the Council of Economic Advisors. Medicine Shoppe, also of St. Louis, is the largest franchisor of pharmacies in the U.S., with over 880 stores operating nationally. Medicine Shoppe president David Abahamson stated that Weidenbaum's "experience will be of great value to the board, particularly as it considers the future direction of health care services in the United States and possible private and public proposals for changes in the delivery of health care."

American Health Services Corp., Newport Beach, Calif., added Lloyd Glazer to its board. Glazer is an associate director of Bear Stearns. "He brings to the board over 20 years experience in the investment banking industry," said American Health president and CEO F. Larry Atkins. "His perspective with regard to the future financing requirements of American Health will be invaluable." The company develops and operates diagnostic treatment centers affiliated with health care providers and is the largest operator of fixed-site, hospital-based diagnostic imaging centers in the U.S.

American Biogenetic Sciences Inc. elected Robert L. Dilenschneider to its board. Before forming his own public relations firm, The Dilenschneider Group, he spent most of his career with Hill & Knowlton Inc., a leading public relations firm, where he rose to president and CEO. He left Hill & Knowlton in September 1991."His communications expertise will serve the company well," said Henry Nordhoff, president of American Biogenetic Sciences. ABS, of Notre Dame, Ind., conducts research at the University of Notre Dame and at Trinity College in Ireland to develop and commercialize monoclonal antibody-based products for treating cardiovascular disease and for diagnosing Alzheimer's disease.

Electromedics Inc., Englewood, Colo., has added Dr. Algernon G. Swan to its board. Swan is the president of Triangle MicroSystems Inc., a control systems company. He has served as the chief of the Air Force Biophysics Laboratories and the director of research and development for the Air Force Aerospace Medical Center. In the 1970s he served with Becton Dickinson & Co. as corporate director of research. Electromedics designs and markets medical equipment and associated disposable devices focusing on blood management and blood conservation.

Epitope Inc. elected Richard K. Donahue, president and COO of Nike Inc., to its board. Donahue joined Nike as COO in 1990, and served as a member of its board since 1977. Prior to joining Nike in a full-time executive position, Donahue practiced law in Lowell, Mass. Epitope, of Beaverton, Ore., is using biotechnology to develop diagnostic tests for AIDS, therapeutic antimicrobial drugs and, through its agricultural unit, superior new plant varieties.

Genetics Institute Inc., Cambridge, Mass., added James Andress to its board. Andress had previously held top executive posts in several leading pharmaceutical companies, most recently as chairman of SmithKline Beecham PLC of London and president and COO of Sterling Drug Inc. in New York. Prior to joining Sterling, Andress served for 10 years in several key management positions at Abbott Laboratories Inc. Genetics Institute is engaged in the development of pharmaceuticals through recombinant DNA and other technologies.

Orthomet Inc. elected C. McCollister Evarts, M.D., to its board. Dr. Evarts is senior vice president for health affairs of Pennsylvania State University and dean of the university's College of Medicine, at the Milton S. Hershey Medical Center. "He brings a rare breadth and depth of industry knowledge as an educator, clinical researcher, administrator, and orthopedic surgeon, combined with a business perspective," states Donald R. Brattain, Orthomet chairman. Based in Minneapolis, Orthomet designs, manufactures, and markets orthopedic products, primarily reconstructive knee and hip implants and related surgical instrumentation.

Royce Laboratories Inc., Miami, added Dr. David Cohen and William Grant to its board. Cohen is the president of Guidelines Inc., of Miami, a consulting company specializing in pharmaceutical development and regulatory affairs. From 1977 to 1986 he had been vice president of quality assurance and regulatory affairs for Key Pharmaceuticals Inc. Grant has served as president of Grant & Associates, a Tallahassee, Fla.-based consulting firm specializing in government affairs and real estate, since January 1991. For the four years prior, he had served as a U.S. congressman. The two new directors come aboard "at a time when we are planning for a major expansion of our business," says President Patrick J. McEnany. Royce Laboratories is a manufacturer of prescription and over-the-counter pharmaceuticals.

American Healthcorp Inc., Nashville, Tenn., elected Frank A. Ehmann to its board. Ehmann had a 28-year career with American Hospital Supply Corp. and was its president and COO when that company merged with Baxtor-Travenol Laboratories Inc. in 1985. He currently is a partner of RCS Health Care Partners Ltd., an affiliate of Robertson Stephens & Co., and also serves as a director of St. Jude Medical Inc. and several other companies. He left Baxter-Travenol in 1986, and from 1987 to 1989 was president and COO of United Stationers Inc. American Healthcorp, through its wholly owned subsidiary, Diabetes Treatment Centers of America Inc., is the leading provider of comprehensive diabetes treatment services in the U.S. The company completed its initial public offering in August 1991.
COPYRIGHT 1992 Directors and Boards
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Directors & Boards
Date:Jan 1, 1992
Previous Article:Key organization issues for the board.
Next Article:Hans Mueller, Nova Pharmaceutical.

Related Articles
Recruiting and retaining IT staff.
The Health Care Industry: Alaska's New Bread and Butter.
Association health plans will provide franchising community new health care options: "but the No. 1 problem facing small business in this country...
Hire education: demographics, analytics and health care reform are changing the way insurance recruiters fill jobs.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters